(C) B2Bioworld 2016 artwork innovationManagement of Innovation in the Chemicals Industry
- The example of Evonik

February 2016. What means innovation in the chemicals sector facing global competition, managing heterogeneous human resources, and having to deal with multiple jurisdictions? Which tools have been found to spur internal development in a way to turn IP protect into profitability? Peter Nagler, Head of Innovation Evonik Industries AG with global responsibility shares his experience participating in research and product development from Degussa up to Evonik, as well as testing many organisational development tools for their practical uses in daily work.

If you like to read this article, you can purchase it now

Please notice, when purchasing articles you agree to B2Bioworld's Terms and Conditions

Read Now - Please select your license (Prices incl. 7% VAT)
7 pages free of advertisements

Article free of advertisement - 7 pages
- Includes informative graphic materials, e.g. commented chart of Evonik Industries R&D sites worldwide

Full Company License enquire here

Back to section

Related Editorial Articles

B2Bioworld offers you background information

Resolving the Innovation Paradox
Günter von Au, Vice-Chairman of the Board, Clariant AG and former CEO of Süd-Chemie. Includes an assessments of CHOREN’s failure and the Brazilian demand for cellulosic ethanol

Renmatix: Modeling conversion of woody biomass at industrial scale

Sustainability refers to more than “green” or “bio-based”
Giorgio Squinzi, President of construction chemicals corporation MAPEI SpA and of Italy’s Confindustria

Thermo Fisher’s BRIMS-Strategy under Testing

Plant Genetic Engineering: It's not as simple as Yes or No !
Nobel Prize laureate Prof. Christiane Nüsslein-Volhard Warns of GMO-populism and researchers not standing up. Exclusive interview for readers of B2Bioworld

What Future for the Chemicals Industry?
Stefan Marcinowski, past Member of the Board of Executive Directors of BASF SE

The German Way towards Bio-Economy
Christine Lang, Co-Chair of the German Bioeconomy Council outlines perspectives beyond Germany

CO2 as resource for specialty chemicals: What makes it difficult for industry

Industrial Bioscience: Solutions Marketing Never Dreamt of…
Bayer CropScience: Hidden Potentials, Revaluation of IP Assets, and Substantial Changes in R&D

Lobbying Lignocellulosic Ethanol Plants: “Some expectations were very aggressive…”
Christopher Standlee, VP Global Affairs for Abengoa on politics in the U.S., and his company’s strategic perspective on Brazil and Europe

Sekisui Chemicals Taps Syngas Expertise

Corporate Compliance: Training the paper tiger to purr, show its teeth, or jump on
Michael Schulz, former CFO and Compliance Officer of Bayer CropScience describes the workings of the system

Bioeconomy offers Europe and Russia opportunity for long-term strategic cooperation
Esko Aho, Göran Persson, and Marc Palahí